Investor Presentaiton

TC BIOPHARM Three lots of TCB008 were tested against a panel of AML cell lines for their ability to specifically eradicate/kill the cancer cells TCB008 Cytotoxicity Against AML Cell Lines • TCB008 Lot 1 - TCB008 Lot 2 - TCB008 Lot 3 • Within 24 hours of exposure of AML cell lines to TCB008 drug product, TCB008 exhibited substantial cytotoxic effects against all 3 AML cell lines. • TCB008 lots were manufactured from 3 different starting material donors that met TCBP's criteria for selection E = Effectors THP-1 HL-60 MV-4-11 H T = Targets 100. 80- 60. 60 specific cell death (%) 40. 40 AHAL 20. 20 H H H HH HOH H 0 0.5:11:1 2:1 4:1 8:1 0.5:1 1:1 2:1 4:1 8:1 0.5:1 1:1 2:1 4:1 8:1 E:T 7

View entire presentation